Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 33.50
-0.95 (-2.76%)
At close: Jan 28, 2026
SHE:301263 Revenue
Guangdong Taienkang Pharmaceutical had revenue of 178.75M CNY in the quarter ending September 30, 2025, with 1.02% growth. This brings the company's revenue in the last twelve months to 674.49M, down -10.31% year-over-year. In the year 2024, Guangdong Taienkang Pharmaceutical had annual revenue of 721.03M, down -5.23%.
Revenue (ttm)
674.49M
Revenue Growth
-10.31%
P/S Ratio
19.78
Revenue / Employee
623.95K
Employees
1,081
Market Cap
13.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 721.03M | -39.76M | -5.23% |
| Jan 1, 2024 | 760.79M | -22.69M | -2.90% |
| Jan 1, 2023 | 783.48M | 129.83M | 19.86% |
| Jan 1, 2022 | 653.65M | -55.33M | -7.80% |
| Dec 31, 2020 | 708.98M | 212.59M | 42.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Zhejiang Medicine | 8.96B |
| Guobang Pharma | 5.94B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Porton Pharma Solutions | 3.43B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |